AMY HITCHENS: Open Payments
NPI 1356730311 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,868 in 117 payments from 24 companies in 2025. Trend: 2023 $897 · 2024 $2,209 · 2025 $2,868
Food & beverage: $2,620Consulting: $150Education: $98
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $543 |
| GENZYME CORPORATION | 13 | $428 |
| Regeneron Healthcare Solutions, Inc. | 10 | $229 |
| JAZZ PHARMACEUTICALS INC. | 4 | $224 |
| Verona Pharma, Inc. | 15 | $216 |
| GlaxoSmithKline, LLC. | 16 | $208 |
| Axsome Therapeutics, Inc. | 10 | $190 |
| HARMONY BIOSCIENCES LLC | 3 | $112 |
| United Therapeutics Corporation | 5 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $102 |
Products named: DUPIXENT, BREZTRI, XYWAV, Ohtuvayre, FASENRA, Sunosi, TRELEGY ELLIPTA, WAKIX.
Industry payments across DE — which companies pay providers there.
